167 related articles for article (PubMed ID: 35685993)
1. Genomic landscape of T-cell lymphoblastic lymphoma.
Li Z; Song Y; Zhang M; Wei Y; Ruan H
Chin J Cancer Res; 2022 Apr; 34(2):83-94. PubMed ID: 35685993
[TBL] [Abstract][Full Text] [Related]
2. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract][Full Text] [Related]
3. Genomic signatures and prognosis of advanced stage Chinese pediatric T cell lymphoblastic lymphoma by whole exome sequencing.
Liu Q; Yu X; Wen J; Yin N; Liao X; Zou P; Guo Y; Song L; Xiao J
Front Pediatr; 2023; 11():1224966. PubMed ID: 37664545
[TBL] [Abstract][Full Text] [Related]
4. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
[TBL] [Abstract][Full Text] [Related]
5. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
[TBL] [Abstract][Full Text] [Related]
7. Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Kroeze E; Iaccarino I; Kleisman MM; Mondal M; Beder T; Khouja M; Höppner MP; Scheijde-Vermeulen MA; Kester LA; Brüggemann M; Baldus CD; Cario G; Bladergroen RS; Garnier N; Attarbaschi A; Verdu-Amorós J; Sutton R; Macintyre EA; Scholten K; Arias Padilla L; Burkhardt B; Beishuizen A; den Boer ML; Kuiper RP; Loeffen JLC; Boer JM; Klapper W
Blood; 2024 Apr; ():. PubMed ID: 38588489
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma.
Huang YH; Wan CL; Dai HP; Xue SL
Ann Hematol; 2023 Aug; 102(8):2001-2013. PubMed ID: 37227492
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomic analysis of pediatric T-cell lymphoblastic lymphoma reveals candidates of clinical significance.
Khanam T; Sandmann S; Seggewiss J; Ruether C; Zimmermann M; Norvil AB; Bartenhagen C; Randau G; Mueller S; Herbrueggen H; Hoffmann P; Herms S; Wei L; Woeste M; Wuensch C; Gowher H; Oschlies I; Klapper W; Woessmann W; Dugas M; Burkhardt B
Blood; 2021 Apr; 137(17):2347-2359. PubMed ID: 33152759
[TBL] [Abstract][Full Text] [Related]
10. Failure of tofacitinib to achieve an objective response in a
Wong J; Wall M; Corboy GP; Taubenheim N; Gregory GP; Opat S; Shortt J
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843425
[TBL] [Abstract][Full Text] [Related]
11. Design of a targeted next-generation DNA sequencing panel for pediatric T-cell lymphoblastic lymphoma to unravel biology and optimize treatment.
Ruether C; Wuensch C; Randau G; Michgehl U; Trautmann M; Hartmann W; Sandmann S; Dugas M; Khanam T; Burkhardt B
Genes Chromosomes Cancer; 2022 Aug; 61(8):459-470. PubMed ID: 35278000
[TBL] [Abstract][Full Text] [Related]
12. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
[TBL] [Abstract][Full Text] [Related]
13. Co-existence of
Li M; Xiao L; Xu J; Zhang R; Guo J; Olson J; Wu Y; Li J; Song C; Ge Z
Oncol Lett; 2016 Jul; 12(1):16-22. PubMed ID: 27347093
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma.
Zou Q; Ma S; Tian X; Cai Q
Blood Sci; 2022 Jul; 4(3):155-160. PubMed ID: 36518593
[TBL] [Abstract][Full Text] [Related]
15. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
[TBL] [Abstract][Full Text] [Related]
16. T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.
Basso K; Mussolin L; Lettieri A; Brahmachary M; Lim WK; Califano A; Basso G; Biondi A; Cazzaniga G; Rosolen A
Genes Chromosomes Cancer; 2011 Dec; 50(12):1063-75. PubMed ID: 21987448
[TBL] [Abstract][Full Text] [Related]
17. Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development.
Roncero AM; López-Nieva P; Cobos-Fernández MA; Villa-Morales M; González-Sánchez L; López-Lorenzo JL; Llamas P; Ayuso C; Rodríguez-Pinilla SM; Arriba MC; Piris MA; Fernández-Navarro P; Fernández AF; Fraga MF; Santos J; Fernández-Piqueras J
Leukemia; 2016 Jan; 30(1):94-103. PubMed ID: 26216197
[TBL] [Abstract][Full Text] [Related]
18. PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
Yuan S; Wang X; Hou S; Guo T; Lan Y; Yang S; Zhao F; Gao J; Wang Y; Chu Y; Shi J; Cheng T; Yuan W
Leukemia; 2022 Feb; 36(2):370-382. PubMed ID: 34465864
[TBL] [Abstract][Full Text] [Related]
19. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
20. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]